Innovative Neurotech NeuraLight's advanced platform leverages breakthrough AI and neuroscience research to provide precise brain function measurements, positioning it as a valuable partner for healthcare providers and research institutions seeking innovative diagnostic and monitoring solutions.

Strong Industry Recognition Being recognized as a finalist for the Prix Galien USA Award and endorsed by leading neurologists and research foundations highlights NeuraLight's credibility and potential for expanding collaborations within the medical and biotech sectors.

Expanding Clinical Collaborations Recent partnerships with organizations like CHDI Foundation and ongoing research in Parkinson’s and Huntington’s diseases suggest significant opportunities to offer tailored biomarkers and measurement tools to pharma companies and clinical trial sponsors focused on neurodegenerative diseases.

Growing Market Presence Participation in major industry events and launching longitudinal trials demonstrate active engagement in the neurology space, which can open doors for sales of NeuroLight's research-grade measurement solutions to neurologists, research hospitals, and pharmaceutical firms developing treatments.

Market Opportunity With revenue ranging from 10 to 25 million USD and a relatively small team, NeuraLight is poised for rapid growth, creating opportunities for business development efforts focused on expanding client base among neurohealth research organizations, clinical trial providers, and pharmaceutical innovators.